Sanofi (Genzyme Flanders)

Cipalstraat 8

2440 Geel

BE

Sanofi (Genzyme Flanders)

Foundation date

30/10/2001

Sector

#Biotechnology - Therapeutics

As the specialty care global business unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    1 day ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022